Amantadine Hcl
Brand name: Amantadine
Rank #270 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$45.2M
Total Cost
173,840
Total Claims
$45.2M
Total Cost
6,009
Prescribers
$260
Cost per Claim
17,808
Beneficiaries
252,270
30-Day Fills
$7,525
Avg Cost/Provider
29
Avg Claims/Provider
Share of Medicare Part D Spending
0.02%
of total Medicare Part D spending
$45.2M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $45.2M total
Top Prescribers of Amantadine Hcl
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Andres Deik Acosta Madiedo | Neurology | Philadelphia, PA | 230 | $752K |
| 2 | Rajesh Pahwa | Neurology | Kansas City, KS | 222 | $752K |
| 3 | Cenk Sengun | Neurology | Boca Raton, FL | 114 | $575K |
| 4 | Martha Mcgraw | Neurology | Winfield, IL | 137 | $545K |
| 5 | Ramsey Falconer | Neurology | Alexandria, VA | 125 | $517K |
| 6 | Danielle Englert Doggett | Neurology | Charlotte, NC | 160 | $496K |
| 7 | Kathleen Woschkolup | Neurology | Greenville, SC | 147 | $484K |
| 8 | Guy Schwartz | Neurology | East Setauket, NY | 199 | $481K |
| 9 | Catherine Claro | Nurse Practitioner | New York, NY | 128 | $458K |
| 10 | Sanjay Iyer | Neurology | Charlotte, NC | 138 | $434K |
| 11 | Daniel Kremens | Neurology | Philadelphia, PA | 111 | $390K |
| 12 | Jessica Lawton | Physician Assistant | Mystic, CT | 158 | $366K |
| 13 | Stuart Isaacson | Neurology | Boca Raton, FL | 97 | $347K |
| 14 | Sherrie Gould | Nurse Practitioner | La Jolla, CA | 102 | $343K |
| 15 | Sotirios Parashos | Neurology | St Louis Park, MN | 108 | $302K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 267 | C1 Esterase Inhibitor (Haegarda) | $45.8M | 894 |
| 268 | Alectinib Hcl (Alecensa) | $45.7M | 2,686 |
| 269 | Ipratropium Bromide (Ipratropium Bromide) | $45.4M | 656,249 |
| 270 | Amantadine Hcl (Amantadine) | $45.2M | 173,840 |
| 271 | Insulin Nph Human Isophane (Humulin N) | $44.9M | 172,714 |
| 272 | Bosutinib (Bosulif) | $44.9M | 2,962 |
| 273 | Tramadol Hcl (Tramadol Hcl) | $44.9M | 5,226,406 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology